BROVANEXINE
UNII Y00SD533IW

Substance Identification & Data

This profile provides standardized clinical and technical data for Brovanexine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y00SD533IW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54340-61-3 and the RxNorm Concept ID (RxCUI) 19791. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y00SD533IW

CAS Registry Number

54340-61-3

RxNorm Concept ID

19791

Detailed Substance Profile

Preferred Name

BROVANEXINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H28Br2N2O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DQTRREPKGJIABH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C74261

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

162137

Unique identification number in the NCBI database of chemical substances.

INN ID

3527

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(c1cc(c(cc1)OC(=O)C)OC)(=O)Nc2c(cc(cc2CN(C)C3CCCCC3)Br)Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brovanexine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.